Emerald Advisers’s ATI Physical Therapy, Inc. ATIP Stock Holding History

Emerald Advisers’s Portfolio ATIP Stock Details ATIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-310	Closed	-$29K	–	280
2022 Q1	$29K	Sell	310 -40	-11%	-$5.09K	﹤0.01%	249
2021 Q4	$59K	Buy	+350	New	+$59K	﹤0.01%	255

Other funds holding ATIP

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

GGH

GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return

KCM

Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return

VCM

Venor Capital Management New York $58.9M AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emerald Advisers's ATIP Position: Q2 2022 in Review

Emerald Advisers sold out of ATI Physical Therapy, Inc. (ATIP) in Q2 2022, closing a stake of 310 shares — an estimated $29K sold.

Emerald Advisers first reported a position in ATIP in Q4 2021 and held it in 2 quarters. The position peaked at $59K in Q4 2021. 96 funds tracked by Wall St. Rank hold ATIP as of Q2 2022.

Emerald Advisers reported no remaining ATI Physical Therapy, Inc. position as of Q2 2022 after selling out during the quarter.
Emerald Advisers sold 310 ATI Physical Therapy, Inc. shares in Q2 2022, an estimated $29K.
Emerald Advisers first reported a position in ATI Physical Therapy, Inc. in Q4 2021 and held it in 2 quarters.
Emerald Advisers's ATI Physical Therapy, Inc. position peaked at $59K in Q4 2021.
96 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. as of Q2 2022.

Based on Emerald Advisers's 13F filing for Q2 2022, filed 29 Jul 2022.